Results 31 to 40 of about 690,948 (299)

Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19

open access: yesNature Immunology, 2023
Gastrointestinal fungal dysbiosis is a hallmark of several diseases marked by systemic immune activation. Whether persistent pathobiont colonization during immune alterations and impaired gut barrier function has a durable impact on host immunity is ...
Takato Kusakabe   +23 more
semanticscholar   +1 more source

Dermatological diseases presented before COVID‐19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID‐19?

open access: yesDermatologic Therapy, 2020
Recent studies have focused on the comorbid conditions of the COVID‐19. According to the current studies, numerous diseases including lung disease, cardiovascular disease and immunosuppression appear to be at higher risk for severe forms of the COVID‐19.
Ömer Kutlu, A. Metin
semanticscholar   +1 more source

Cavitary Lung Diseases: A Clinical‐Radiologic Algorithmic Approach

open access: yesChest, 2018
&NA; Cavities occasionally are encountered on thoracic images. Their differential diagnosis is large and includes, among others, various infections, autoimmune conditions, and primary and metastatic malignancies. We offer an algorithmic approach to their
K. Gafoor   +15 more
semanticscholar   +1 more source

Coronavirus Disease 2019–Associated Invasive Fungal Infection

open access: yesOpen Forum Infectious Diseases, 2021
Coronavirus disease 2019 (COVID-19) can become complicated by secondary invasive fungal infections (IFIs), stemming primarily from severe lung damage and immunologic deficits associated with the virus or immunomodulatory therapy.
J. Baddley   +11 more
semanticscholar   +1 more source

Disseminated Scedosporium apiospermum central nervous system infection after lung transplantation: A case report with successful recovery

open access: yesMedical Mycology Case Reports, 2019
Scedosporium species are fungal opportunistic pathogens frequently seen in chronic lung diseases such as in cystic fibrosis (CF). They can cause a wide spectrum of diseases mainly in immunodeficient patients.
Juuso Paajanen   +3 more
doaj   +1 more source

Homobifunctional imidoester-modified zinc nano-spindle attenuated hyphae growth of Aspergillus against hypersensitivity responses

open access: yesiScience, 2023
Summary: Fungi cause various forms of invasive fungal disease (IFD), and fungal sensitization can contribute to the development of asthma, asthma severity, and other hypersensitivity diseases, such as atopic dermatitis (AD). In this study, we introduce a
Huifang Liu   +8 more
doaj   +1 more source

Fungal Lung Disease

open access: yes, 2020
Munje R, Mishra G. Fungal Lung Disease. In: Pulmonary Clinics of India - 4 (Annual Journal of Academy of Respiratory Medicine). Academy of Respiratory Medicine; 2018. p. 117–44. A chapter on Fungal Lung diseases published in Pulmonary Clinics of India - 4 (Annual Journal of Academy of Respiratory Medicine).
Munje, Radha, Mishra, Gyanshankar
openaire   +1 more source

The Role of Infection in Interstitial Lung Diseases

open access: yesChest, 2017
&NA; Interstitial lung disease (ILD) comprises an array of heterogeneous parenchymal lung diseases that are associated with a spectrum of pathologic, radiologic, and clinical manifestations. There are ILDs with known causes and those that are idiopathic,
N. Azadeh, A. Limper, E. Carmona, J. Ryu
semanticscholar   +1 more source

Regulation of lung inflammation by adiponectin

open access: yesFrontiers in Immunology, 2023
Adiponectin is an insulin sensitizing hormone that also plays a role in the regulation of inflammation. Although adiponectin can exert pro-inflammatory effects, more studies have reported anti-inflammatory effects, even in non-adipose tissues such as the
Joo-Yeon Lim, Steven P. Templeton
semanticscholar   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy